
    Original Text: Patients may not be receiving any other investigational agents and may not have participated in a study of an investigational agent or using an investigational device within 4 weeks of the first dose of treatment
    Disease/Condition: none
    Procedure: Investigational Agent
    Drug: none
    Biomarker: none
    Computable Rule: "Investigational Agent" is False and "Investigational Device" is False

Criterion:
    Patients with metastatic colorectal cancer (mCRC) who have failed to respond to or progressed on standard chemotherapy regimens, including fluoropyrimidine-based therapies, oxaliplatin, irinotecan, and anti-VEGF antibodies

Output:
    Original Text: Patients with metastatic colorectal cancer (mCRC) who have failed to respond to or progressed on standard chemotherapy regimens, including fluoropyrimidine-based therapies, oxaliplatin, irinotecan, and anti-VEGF antibodies
    D